Nicolai Juul Birkbak

Zitiert von

	Alle	Seit 2019
Zitate	27632	21312
h-index	62	57
i10-index	91	86

4400

2200

1100

3300

20112012201320142015201620172018201920202021202220232024159 232 293 478 636 890 1369 1993 2626 3522 4332 4075 3949 2781

Öffentlicher Zugriff

Alle anzeigen

83 Artikel

3 Artikel

verfügbar

nicht verfügbar

Basierend auf Fördermandaten

Koautoren

Charles SwantonFrancis Crick InstituteBestätigte E-Mail-Adresse bei crick.ac.uk
Zoltan SzallasiHarvard Medical SchoolBestätigte E-Mail-Adresse bei childrens.harvard.edu
Aron Charles EklundClinical Microbiomics A/SBestätigte E-Mail-Adresse bei clinical-microbiomics.com
Nicholas McGranahanGroup Leader, CRUK Lung Cancer Centre of Excellence, UCL Cancer InstituteBestätigte E-Mail-Adresse bei ucl.ac.uk
Andrea L RichardsonAssociate Professor of Pathology and Oncology, Johns Hopkins University School of MedicineBestätigte E-Mail-Adresse bei jhmi.edu
Hugo AertsDirector AI in Medicine (AIM) @ Harvard-MGB | Professor @ MaastrichtUBestätigte E-Mail-Adresse bei dfci.harvard.edu
Qiyuan LiSchool of Medicine, Xiamen UniversityBestätigte E-Mail-Adresse bei xmu.edu.cn
Andrew J RowanPrincipal Laboratory Research Scientist, Francis Crick InstituteBestätigte E-Mail-Adresse bei crick.ac.uk
Benjamin Haibe-KainsScientist (Principal Investigator), Princess Margaret Cancer Centre, University Health NetworkBestätigte E-Mail-Adresse bei uhnresearch.ca
John QuackenbushHarvard T.H. Chan School of Public Health, Channing Division of Network Medicine, and Dana-FarberBestätigte E-Mail-Adresse bei hsph.harvard.edu
Francesco FaveroCopenhagen UniversityBestätigte E-Mail-Adresse bei bric.ku.dk
Chris AbboshAstraZenecaBestätigte E-Mail-Adresse bei astrazeneca.com
Andrew H. BeckCo-Founder and CEO at PathAIBestätigte E-Mail-Adresse bei PathAI.com
Marcin KrzystanekAssistant Professor, Technical University of DenmarkBestätigte E-Mail-Adresse bei cbs.dtu.dk
Mariam Jamal-HanjaniUCL Cancer InstituteBestätigte E-Mail-Adresse bei doctors.org.uk
Andrea Marion MarquardPostdoc, Technical University of DenmarkBestätigte E-Mail-Adresse bei dtu.dk
Gareth WilsonFrancis Crick Institute, UCL Cancer InstituteBestätigte E-Mail-Adresse bei crick.ac.uk
Rebecca A BurrellUniversity of CambridgeBestätigte E-Mail-Adresse bei cruk.cam.ac.uk
Prof Marco GerlingerBarts Cancer Institute, London, UKBestätigte E-Mail-Adresse bei qmul.ac.uk
Kevin LITCHFIELDResearch Leader - Isomorphic Labs (Alphabet company), Honorary Group Leader - UCLBestätigte E-Mail-Adresse bei google.com

Folgen

Nicolai Juul Birkbak

Associate professor, Department of Molecular Medicine (MOMA), Aarhus University

Bestätigte E-Mail-Adresse bei clin.au.dk - Startseite

Cancer Biology Bioinformatics Intratumor heterogeneity NGS sequencing DNA repair


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade N McGranahan, AJS Furness, R Rosenthal, S Ramskov, R Lyngaa, ... Science 351 (6280), 1463-1469, 2016	3060	2016
Tracking the evolution of non–small-cell lung cancer M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ... New England Journal of Medicine 376 (22), 2109-2121, 2017	2262	2017
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ... Nature 545 (7655), 446-451, 2017	1760	2017
Artificial intelligence in cancer imaging: clinical challenges and applications WL Bi, A Hosny, MB Schabath, ML Giger, NJ Birkbak, A Mehrtash, ... CA: a cancer journal for clinicians 69 (2), 127-157, 2019	1447	2019
Chromosomal instability drives metastasis through a cytosolic DNA response SF Bakhoum, B Ngo, AM Laughney, JA Cavallo, CJ Murphy, P Ly, P Shah, ... Nature 553 (7689), 467-472, 2018	1288	2018
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer DP Silver, AL Richardson, AC Eklund, ZC Wang, Z Szallasi, Q Li, N Juul, ... Journal of clinical oncology 28 (7), 1145-1153, 2010	1268	2010
Allele-specific HLA loss and immune escape in lung cancer evolution N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ... Cell 171 (6), 1259-1271. e11, 2017	1218	2017
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis S Turajlic, K Litchfield, H Xu, R Rosenthal, N McGranahan, JL Reading, ... The lancet oncology 18 (8), 1009-1021, 2017	893	2017
Neoantigen-directed immune escape in lung cancer evolution R Rosenthal, EL Cadieux, R Salgado, MA Bakir, DA Moore, CT Hiley, ... Nature 567 (7749), 479-485, 2019	773	2019
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution N McGranahan, F Favero, EC De Bruin, NJ Birkbak, Z Szallasi, ... Science translational medicine 7 (283), 283ra54-283ra54, 2015	724	2015
Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data F Favero, T Joshi, AM Marquard, NJ Birkbak, M Krzystanek, Q Li, ... Annals of Oncology 26 (1), 64-70, 2015	709	2015
Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal S Turajlic, H Xu, K Litchfield, A Rowan, S Horswell, T Chambers, ... Cell 173 (3), 595-610. e11, 2018	577	2018
Inconsistency in large pharmacogenomic studies B Haibe-Kains, N El-Hachem, NJ Birkbak, AC Jin, AH Beck, HJWL Aerts, ... Nature 504 (7480), 389-393, 2013	570	2013
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents NJ Birkbak, ZC Wang, JY Kim, AC Eklund, Q Li, R Tian, C Bowman-Colin, ... Cancer discovery 2 (4), 366-375, 2012	569	2012
Fc effector function contributes to the activity of human anti-CTLA-4 antibodies FA Vargas, AJS Furness, K Litchfield, K Joshi, R Rosenthal, E Ghorani, ... Cancer cell 33 (4), 649-663. e4, 2018	559	2018
MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling SJ Song, L Poliseno, MS Song, U Ala, K Webster, C Ng, G Beringer, ... Cell 154 (2), 311-324, 2013	529	2013
Chromosomal instability confers intrinsic multidrug resistance AJX Lee, D Endesfelder, AJ Rowan, A Walther, NJ Birkbak, PA Futreal, ... Cancer research 71 (5), 1858-1870, 2011	526	2011
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers CM Blakely, TBK Watkins, W Wu, B Gini, JJ Chabon, CE McCoach, ... Nature genetics 49 (12), 1693-1704, 2017	500	2017
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers S Trebeschi, SG Drago, NJ Birkbak, I Kurilova, AM Cǎlin, AD Pizzi, ... Annals of Oncology 30 (6), 998-1004, 2019	463	2019
Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ... Immunity 46 (4), 577-586, 2017	428	2017

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Folgen

Zitiert von

Koautoren